Targeted Identification of Sialoglycoproteins in Hypoxic Endothelial Cells and Validation in Zebrafish Reveal Roles for Proteins in Angiogenesis
Delcourt, Nicolas, Quevedo, Celia, Nonne, Christelle, Fons, Pierre, O'Brien, Donogh, Loyaux, Denis, Diez, Maria, Autelitano, François, Guillemot, Jean-Claude, Ferrara, Pascual, Muriana, Arantza, Callol, Carlos, Hérault, Jean-Pascal, Herbert, Jean-Marc, Favre, Gilles, Bono, Françoise
Published in The Journal of biological chemistry (06.02.2015)
Published in The Journal of biological chemistry (06.02.2015)
Get full text
Journal Article
Abstract 1731: EXS21546, a non-CNS penetrant A2AR-selective antagonist for anti-cancer immunotherapy
Payne, Andrew, Fons, Pierre, Alt, Isabella, van Ham, Joost, Taubert, Christina, Bell, Andy, Versluys, Stephanie, Bertrand, Florie, Visentin, Virgile, Mirey, Emilie, Pelissier, Emilie, Paillasse, Michael, Pagliarusco, Sabrina, Vladimer, Gregory, Whittaker, Mark
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration
Favier, Benoit, Alam, Antoine, Barron, Pauline, Bonnin, Jacques, Laboudie, Patricia, Fons, Pierre, Mandron, Marie, Herault, Jean-Pascal, Neufeld, Gera, Savi, Pierre, Herbert, Jean-Marc, Bono, Françoise
Published in Blood (15.08.2006)
Published in Blood (15.08.2006)
Get full text
Journal Article
Abstract CT088: EVT801, a novel selective VEGFR-3 inhibitor targeting tumor angiogenesis, is pursuing dose escalation stage of phase I first-in-human study
Gomez-Roca, Carlos, Cassier, Philippe, Fitzgerald, Michael, Davenne, Lise, Costantin, Cristina, Rochaix, Philippe, Delord, Jean-Pierre, Friend, John, Nizzardo, Andrea, Tagliavini, Alessia, Pergher, Marco, Fons, Pierre, Mandron, Marie
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article
Abstract 4079: EVT801: a selective VEGFR3 inhibitor with the potential for combination with immune-checkpoint therapies, preclinical evidences and plans for first-in-human evaluation
Fons, Pierre, Esquerre, Michael, Paillasse, Michael, Visentin, Virgile, Dol, Frederique, Meneyrol, Jerome, Badet, Gaelle, Cogo, Eric, Vidaud, Lionel, Alam, Antoine, Blanc, Isabelle, Bono, Francoise, Lisztwan, Joanna, Poublanc, Muriel, Filleron, Thomas, Hunneyball, Ian, Delord, Jean-Pierre, Whittaker, Mark
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Baseline circulating myeloid-derived suppressor cells and response to PD-1 inhibitor in non-small cell lung cancer patients
Delaunay, Myriam, Guibert, Nicolas, Lusque, Amellie, Farella, Magali, Boubekeur, Nadia, Gouin, Sandrine, Dormoy, Inge, Fons, Pierre, Esquerre, Michael, Favre, Gilles, Pradines, Anne, Mazieres, Julien
Published in Journal of clinical oncology (10.02.2018)
Published in Journal of clinical oncology (10.02.2018)
Get full text
Journal Article
VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis
Zhang, Fan, Tang, Zhongshu, Hou, Xu, Lennartsson, Johan, Li, Yang, Koch, Alexander W, Scotney, Pierre, Lee, Chunsik, Arjunan, Pachiappan, Dong, Lijin, Kumar, Anil, Rissanen, Tuomas T, Wang, Bin, Nagai, Nobuo, Fons, Pierre, Fariss, Robert, Zhang, Yongqing, Wawrousek, Eric, Tansey, Ginger, Raber, James, Fong, Guo-Hua, Ding, Hao, Greenberg, David A, Becker, Kevin G, Herbert, Jean-Marc, Nash, Andrew, Yla-Herttuala, Seppo, Cao, Yihai, Watts, Ryan J, Li, Xuri
Published in Proceedings of the National Academy of Sciences - PNAS (14.04.2009)
Published in Proceedings of the National Academy of Sciences - PNAS (14.04.2009)
Get full text
Journal Article
Abstract 2634: EVT801: Standalone cancer immunotherapy in VEGFR3+ tumors and combination with immune checkpoint therapies in VEGFR3- tumors
Esquerré, Michael, Fons, Pierre, Badet, Gaëlle, Barron, Pauline, Kagan, Jérémy, Alam, Antoine, Meneyrol, Jérôme, Blanc, Isabelle, Broussy, Roselyne, Gaujarengues, Florence, Lisztwan, Joanna, Paillasse, Michael, Whittaker, Mark, Bono, Françoise
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Abstract 3970: Targeting the adenosine immunosuppressive pathway for cancer immunotherapy with small molecule agents
Fons, Pierre, Esquerré, Michael, Versluys, Stéphanie, Mambrini, Gigliola, Paillasse, Michael, Bell, Andy, Schreyer, Adrian, Cox, Richard, Bickerton, Richard, Lisztwan, Joanna, Whittaker, Mark, Bono, Françoise, Johnstone, Craig, Hopkins, Andrew
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Abstract 3768: Identification of a novel non-brain penetrant A2AR inhibitor and proof-of-concept of CD73 and A2AR/CD73 small-molecule inhibitors for cancer immunotherapy
Fons, Pierre, Bell, Andy, Esquerre, Michael, Versluys, Stephanie, Bertrand, Florie, Poussereau-Pomie, Celine, Schreyer, Adrian, Cox, Richard, Besnard, Jeremy, Paillasse, Michael, Swindells, Mark, Lisztwan, Joanna, Johnstone, Craig, Whittaker, Mark, Hopkins, Andrew
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 2753: Translation to the clinic of EVT801: A novel immune-oncology agent for addressing innate-driven immunosuppression into the tumor microenvironment and expanding patient population responding to immune checkpoint therapies
Fons, Pierre, Esquerre, Michael, Mazieres, Julien, Rochaix, Philippe, Gomez-Brouchet, Anne, Alam, Antoine, Bertrand, Florie, Poussereau-Pomie, Celine, Meneyrol, Jerome, Pradines, Anne, selves, janick, Rouquette, Isabelle, Blanc, Isabelle, Bono, Francoise, O'Brien, Donogh P., Paillasse, Michael, Lisztwan, Joanna, Whittaker, Mark
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Abstract 519: EVOEXS21546 is a novel non-brain penetrant A2AR inhibitor for cancer immunotherapy with accelerated drug development
Fons, Pierre, Bell, Andy, Esquerre, Michael, Versluys, Stephanie, Bertrand, Florie, Hopkins-Navratilova, Iva, Robinson, Sean, Visentin, Virgile, Schreyer, Adrian, Cox, Richard, Mirey, Emilie, Pelissier, Emilie, bergeaud, Celia, Culurgioni, Simone, Besnard, Jeremy, Payne, Andrew, Menegotto, Jerome, Machet, Frederic, Poussereau-Pomie, Celine, Cogo, Eric, Paillasse, Michael, Ferigo, Federica, Pagliarusco, Sabrina, Lisztwan, Joanna, Whittaker, Mark, Johnstone, Craig, Hopkins, Andrew
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Abstract 507: Identification of CD73 and A2AR/CD73 small molecule inhibitors for cancer immunotherapy as single agents or in combination with Immune-checkpoint therapies
Fons, Pierre, Bell, Andrew, Esquerre, Michael, Versluys, Stephanie, Bertrand, Florie, Schreyer, Adrian, Hopkins-Navratilova, Iva, Hernani, Leonardo-Silvestre, Bergeaud, Celia, Poussereau-Pomie, Celine, Marchand, Ghislaine, Robinson, Sean, Culurgioni, Simone, Cox, Richard, Besnard, Jeremy, Payne, Andrew, Ray, Peter, Pelissier, Emilie, Paillasse, Michael, Lisztwan, Joanna, Johnstone, Craig, Whittaker, Mark, Hopkins, Andrew
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Abstract 1015: VEGFR-3 expression profiling by histology to classify patient population for the selective VEGFR-3 inhbitor EVT801
Paillasse, michael, Ancey, pierre-benoit, Badet, Gaelle, Gomez-Brouchet, Anne, Selves, Janik, Rochaix, philippe, Battistella, Maxime, Lebbe, Celeste, Cassier, philippe, Gomez-Roca, carlos, Delord, Jean-Pierre, Whittaker, Mark, Davenne, Lise, Friend, John, Fitzgerald, Michael, Garner, James, Fons, Pierre
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Tumor Vasculature Is Regulated by FGF/FGFR Signaling-Mediated Angiogenesis and Bone Marrow-Derived Cell Recruitment: This Mechanism Is Inhibited by SSR128129E, the First Allosteric Antagonist of FGFRs
Fons, Pierre, Gueguen-Dorbes, Geneviève, Herault, Jean-Pascal, Geronimi, Fabien, Tuyaret, Joël, Frédérique, Dol, Schaeffer, Paul, Volle-Challier, Cécile, Herbert, Jean-Marc, Bono, Françoise
Published in Journal of cellular physiology (01.01.2015)
Published in Journal of cellular physiology (01.01.2015)
Get full text
Journal Article
Abstract 1059: Biomarkers analysis on samples from patients in EVT801 clinical trial: Patient characterization and immunomonitoring
Davenne, Lise, Fitzgerald, Michael, Ancey, Pierre-Benoit, Delpuech, Oona, Poussereau-Pomié, Céline, Esquerre, Michael, Paillasse, Michael R., Mandron, Marie, Rochaix, Philippe, Ayyoub, Maha, Scarlata, Clara Maria, Caux, Christine, Caux, Christophe, Cassier, Philippe, Gomez-Roca, Carlos, Delord, Jean-Pierre, Friend, John, Fons, Pierre
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract CT206: EVT801, a novel selective VEGFR-3 inhibitor targeting tumor angiogenesis, started enrollment for its phase I first-in-human study
Gomez roca, Carlos, Cassier, Philippe, Mandron, Marie, Estrabaut, Myriam, Delesque-Touchard, Nathalie, Smith, Adam C., Klawitter, Amy, Gentry, Leesa, Fons, Pierre, Paillasse, Michael R., Davenne, Lise, Fitzgerald, Michael, Garner, James, Delord, Jean-Pierre
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Abstract 4150: Enriching for adenosine antagonist patient responses through deep learning
Alt, Isabella, Shelke, Robert, Lobley, Anna, Baumgaertler, Claudia, Stulic, Maja, Fons, Pierre, Whittaker, Mark, Hackner, Klaus, Dzurillova, Lucia, Petru, Edga, Hadjari, Laudia, Lafleur, Judith, Singer, Josef, Krall, Nikolaus, Hefler, Lukas, Füreder, Thorsten, Taubert, Christina, Boudesco, Christophe, Payne, Andrew, Ian Vladimer, Gregory
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells
Fons, Pierre, Chabot, Sophie, Cartwright, Judith E., Lenfant, Francoise, L'Faqihi, Fatima, Giustiniani, Jerome, Herault, Jean-Pascal, Gueguen, Genevieve, Bono, Françoise, Savi, Pierre, Aguerre-Girr, Maryse, Fournel, Sylvie, Malecaze, François, Bensussan, Armand, Plouët, Jean, Le Bouteiller, Philippe
Published in Blood (15.10.2006)
Published in Blood (15.10.2006)
Get full text
Journal Article
Abstract 3203: Cutting edge biomarkers strategy to provide early insights into activity of EVT-801, a novel selective VEGFR-3 inhibitor that targets tumor angiogenesis during the FIH clinical trial
Paillasse, Michael R., Garner, James, Fitzgerald, Michael, Davenne, Lise, Ancey, Pierre-Benoit, Poussereau-Pomie, celine, Esquerre, Michael, Badet, Gaelle, Tuyaret, Joel, Mandron, Marie, Rochaix, Philippe, Ayyoub, Maha, Scarlata, Clara Maria, Ménétrier-Caux, Christine, CAUX, Chrsitophe, Cassier, Philippe, Delord, Jean-Pierre, Roca, Carlos Gomez, Fons, Pierre
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article